A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic dispersion (0.06% and 0.03% CsA). Administered once daily in combination with lubricant therapy and safety monitoring three months after treatment in patients with moderate to severe xerophthalmia.
RESEARCHER: Dr. Jesús Merayo Lloves ACTIVO A multicentre, randomized, double masked, 4-parallel, controlled, 6-month phase II study to assess the safety and efficacy of a cyclosporine PAD ophthalmic dispersion (0.06% and 0.03% CsA). Administered once daily in combination with lubricant therapy and safety monitoring three months after treatment in patients with moderate to […]
“Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye”
RESEARCHER: Dr. Jesús Merayo Lloves RECLUTANDO “Double-blind, placebo-controlled phase I / II study to assess the efficiency and safety of AVX012 ophthalmic solution in subjects with mild to moderate dry eye” INDICATION: Pacientes con ojo seco leve o moderado TREATMENT: AVX-012 PROMOTOR: Avizorex Pharma
Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.
RESEARCHER: Dr. Álvaro Fernández-Vega Sanz ACTIVO Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye. INDICATION: Patients with Macular Degeneration Associated with the Wet Age TREATMENT: Aflibercept PROMOTOR: Bayer AG
A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab Alone, in Patients with Neovascular Age-Related Macular Degeneration ( Wet AMD)
RESEARCHER: Prof. Luis Fernández-Vega Sanz RECLUTANDO A dose-Ranging, Muti-Centre, Randmised, Double-Mased, Sham-Controlled, Parallel-Group Study of the Efficacy and safety of Opt-302 in Combination wiht Ranibizumab Compared with Ranibizumab Alone, in Patients with Neovascular Age-Related Macular Degeneration ( Wet AMD) INDICATION: Pacientes con degeneración macular asociada a la edad (DMAE húmeda). TREATMENT: OPT-302 PROMOTOR: […]
Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC)
RESEARCHER: Dr. Álvaro Fernández-Vega Sanz ACTIVO Phase IV, randomized, double-blind, simulated control study for the efficacy, safety, and tolerability of Aflibercept intravitreal monotherapy compared to Aflibercept and Concomitant Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy. (ATLANTIC) INDICATION: Patients with polypoid choroidal vasculopathy TREATMENT: Aflibercept PROMOTOR: AIBILI
Phase IV multicentre and single-group interventional study to evaluate a model for the treatment of and extension with intravitreal aflibercept for the treatment of secondary macular edema to the occlusion of the central retinal vein
RESEARCHER: Dr. Álvaro Fernández-Vega Sanz RECLUTANDO
Double masked SYL1001 study in patients with moderate or severe dry eye disease
RESEARCHER: Dr. Jesús Merayo Lloves RECLUTANDO Double masked SYL1001 study in patients with moderate or severe dry eye disease INDICATION: Patients with moderate to severe dry eye TREATMENT: SYL1001 PROMOTOR: SYLENTIS
Charity Eye Care in Guinea-Bissau
![](https://fundacion.fernandez-vega.com/wp-content/uploads/2018/03/foto-ok-1024x676.jpg)
Over 50 patients underwent surgery for severe cataracts and have recovered their eyesight
Eye Care Beyond Our Borders
Thanks to the cooperation of the Asturian Jesuit Kike Figaredo the Fundación Fernández-Vega travelled for the eighth consecutive year to Cambodia to check the eyesight of over 500 individuals. “These check-ups are very important as a large part of academic failure is due to sight problems,” says Dr Parra, who participated in the initiative
Over 550 eye glasses to see Cambodia with a fresh look
![](https://fundacion.fernandez-vega.com/wp-content/uploads/2019/07/IMG-20161117-WA0005-1024x768.jpg)
One of the innovations of this trip was the visit to a camp for political refugees